REVIEW PAPER
Influence of selected autoimmunological diseases on phonation devices, diagnostics and treatment
| 1 | Student Scientific Circle at the Department and Clinic of Otolaryngology, Head and Neck Surgery, Medical University, Wroclaw, Poland |
CORRESPONDING AUTHOR
Daria Markowska
Studenckie Koło Naukowe przy Katedrze i Klinice Otolaryngologii, Chirurgii Głowy i Szyi Uniwersytet Medyczny we Wrocławiu
Studenckie Koło Naukowe przy Katedrze i Klinice Otolaryngologii, Chirurgii Głowy i Szyi Uniwersytet Medyczny we Wrocławiu
J Pre Clin Clin Res. 2023;17(1):27–31
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Many autoimmune diseases correlate with phonatory disorders which significantly reduce the well-being and quality of life of patients due to difficulties in verbal communication. The aim of the review is to present the current medical knowledge on ENT complications in patients suffering from selected autoimmune diseases. The text is partially supplemented with the possibilities of diagnosis and treatment of these disorders.
Review methods:
PubMed, PubMed Central, and printed literature were searched using key words related to phoniatrix, larynx, immunology, voice, thyroid and dysphonia. Articles in Polish, German and English were searched. Bibliographies with outdated data and those that did not have the latest update or did not meet the selected criteria were excluded. Exclusions were most often due to an incomplete topic as well as results reported by an unrepresentative group of patients. The review was supported by an additional case study included as relevant to add significant clinical and imaging value to the work.
Brief description of the state of knowledge:
Autoimmune diseases are manifested in various body systems, including the phonational system. Both patients and doctors often do not expect that symptoms such as hoarseness, dysphonia, low voice or sore throat may be caused by an underlying disease. The list of ailments, diagnostic options and treatment is intended to present this problem and to increase medical awareness.
Summary:
Tthe presented diseases have been shown primarily from the side of disorders in phonation which accompany them. Despite the apparent unrelatedness of the disease with the production of sound, the clinical picture often shows ENT symptoms that are significant for the patient.
Many autoimmune diseases correlate with phonatory disorders which significantly reduce the well-being and quality of life of patients due to difficulties in verbal communication. The aim of the review is to present the current medical knowledge on ENT complications in patients suffering from selected autoimmune diseases. The text is partially supplemented with the possibilities of diagnosis and treatment of these disorders.
Review methods:
PubMed, PubMed Central, and printed literature were searched using key words related to phoniatrix, larynx, immunology, voice, thyroid and dysphonia. Articles in Polish, German and English were searched. Bibliographies with outdated data and those that did not have the latest update or did not meet the selected criteria were excluded. Exclusions were most often due to an incomplete topic as well as results reported by an unrepresentative group of patients. The review was supported by an additional case study included as relevant to add significant clinical and imaging value to the work.
Brief description of the state of knowledge:
Autoimmune diseases are manifested in various body systems, including the phonational system. Both patients and doctors often do not expect that symptoms such as hoarseness, dysphonia, low voice or sore throat may be caused by an underlying disease. The list of ailments, diagnostic options and treatment is intended to present this problem and to increase medical awareness.
Summary:
Tthe presented diseases have been shown primarily from the side of disorders in phonation which accompany them. Despite the apparent unrelatedness of the disease with the production of sound, the clinical picture often shows ENT symptoms that are significant for the patient.
Markowska D, Jurkiewicz K. Influence of selected autoimmunological diseases on phonation devices, diagnostics and treatment. J Pre-Clin Clin Res. 2023; 17(1): 27–31. doi: 10.26444/jpccr/159126
REFERENCES (40)
1.
Kosztyła-Hojna B, Moskal D, Kuryliszyn-Moskal A. Parameters of the assessment of voice quality and clinical manifestation of rheumatoid arthritis. Adv Med Sci. 2015;60(2):321–8.
2.
Roy N, Tanner K, Merrill RM, Wright C, Miller KL, Kendall KA. Descriptive Epidemiology of Voice Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. J Voice. 2016;30(1): 74–87.
3.
Dehghan M, Ahmadi A, Yousefghahari B, Kiakojouri K, Gholinia H. Effects of Rheumatoid Arthritis on the Larynx. Iran J Otorhinolaryngol. 2020;32(110):147–153.
4.
Kırgezen T, Sünter AV, Yiğit Ö, et al. Influence Disease Activity on Voice and Laryngeal Findings of Rheumatoid Arthritis Patients. J Voice. 2020;34(3):451–455.
5.
de Castro M, Dedivitis R, Pfuetzenreiter E, Brandão Barros A, Santos Queija D. Videolaryngostroboscopy and voice evaluation in patients with rheumatoid arthritis. Braz J Otorynolaryngol. 2012;78(5).
6.
Leszczynski P, Pawlak-Bus K. Vocal cords palsy in systemic lupus erythematosus patient: diagnostic and therapeutic difficulties. Rheumatol Int. 2013;33(6):1577–1580.
7.
Ozcan KM, Bahar S, Ozcan I, et al. Laryngeal involvement in systemic lupus erythematosus: report of two cases. J Clin Rheumatol. 2007; 13(5):278–279.
8.
Cairoli E, Tafuri J, Olivari D. Laryngeal histoplasmosis in systemic lupus erythematosus: first reported case. Lupus. 2010;19(11):1354–1355.
9.
Kovacic, Gordana. Voice and hyperthyroidism: Subjective voice complaints and alterations of the acoustic parameters of the voice. Research and Review Insights. 2018; 2.
10.
Syrenicz A, Syrenicz M, Sworczak K, Garanty-Bogacka B. Atypical forms of hyperthyroidism. Endokrynologia Polska. 2006;57:518–24.
11.
Sarkar P, Basu K, Mallick Sinha MG. A Rare Case of Juvenile Systemic Lupus Erythematosus with Disseminated Histoplasmosis. Indian J Dermatol. 2016;61(6):700.
12.
Junuzović-Žunić L, Ibrahimagić A, Altumbabić S. Voice Characteristics in Patients with Thyroid Disorders. Eurasian J Med. 2019;51(2):101–105.
13.
Kovatch KJ, Reyes-Gastelum D, Hughes DT, Hamilton AS, Ward KC, Haymart MR. Assessment of Voice Outcomes Following Surgery for Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(9): 823–829.
14.
Yang S, Zhou L, Lu Z, Ma B, Ji Q, Wang Y. Systematic review with meta-analysis of intraoperative neuromonitoring during thyroidectomy. Int J Surg. 2017;39:104–113.
15.
Ravi R, Gunjawate DR. Effect of diabetes mellitus on voice: a systematic review. Pract Diab, 2019;36:177–180.
16.
Weschenfelder L, Veis V, Leite D. Self-assessment of vocal symptoms and vocal tract discomfort in individuals with type 1 diabetes mellitus. Audiol Commun Res. 2020;25:e2320.
17.
Krajewska-Włodarczyk M, Samborski W. Rola mikrocząsteczek w patogenezie reumatoidalnego zapalenia stawów, Forum Reumatol. 2017;3(3):131–140.
18.
Zhang SX, Ma XW, Li YF, Lai NL, Huang ZH, Fan K, et al. The proportion of regulatory T cells in patients with systemic lupus erythematosus: a meta-analysis. J Immunol Res. 2018:7103219.
19.
Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Physician. 2016 Mar 1;93(5):363–70. PMID: 26926973.
20.
Ejma M, Madetko N, Waliszewska-Prosół M. Neurologiczne powikłania zespołu Sjögrena, Polski Przegląd Neurologiczny. 2017;13(3):120–131.
21.
Hofauer B, Knopf A, Unterhofer C. Ocena zaburzeń krta u pacjentów z zespołem sjögrena. Roczniki Chorób Reumatycznych. 2019;78:1723.
22.
Pierce J, Tanner K, Merrill R, Miller K, Ambati B, Kendall K, Roy N. Voice disorders in Sjögren’s syndrome: Prevalence and related risk factors. The Laryngoscope. 2015;125:1385–1392.
23.
Hamdan AL, Dowli A, Jabbour J, Sabri A, Azar ST. Phonatory symptoms and impact on quality of life in female patients with goiter. Ear Nose Throat J. 2016;95(7):E5–E10.
24.
Foggia M, Hoffman H. Cricoarytenoid joint abscess associated with rheumatoid arthritis. American Journal of Otolaryngology. 2019;40(3): 459–461.
25.
Pradhan P, Bhardwaj A, Venkatachalam V. Bilateral cricoarytenoid arthritis: a cause of recurrent upper airway obstruction in rheumatoid arthritis. The Malaysian journal of medical sciences. 2016;23(3):89.
26.
Bonilha HS, O’Shields M, Gerlach TT, Deliyski DD. Arytenoid adduction asymmetries in persons with and without voice disorders. Logoped Phoniatr Vocol. 2009;34(3):128–34.
27.
Bargigli C, Ciardi G, Corrado B. Zarządzanie rehabilitacją zespołu Charcot-Marie-Tooth: systematyczny przegląd literatury. Medycyna. 2016;95(17).
28.
Knapek M, Wójcik-Topór P. Speech therapy diagnosis of toddlers with vocal fold paralysis A case study. Forum Lingwistyczne. 2022; 10: 1–14.
29.
Dankbaar JW, Pameijer FA. Vocal cord paralysis: anatomy, imaging and pathology. Insights Imaging. 2014;5(6):743–51.
30.
Madden LL, Rosen CA. Evaluation of Vocal Fold Motion Abnormalities: Are We All Seeing the Same Thing? J Voice. 2017;31(1):72–77.
31.
Volk GF, Hagen R, Pototschnig C, Friedrich G, Nawka T, Arens C, Mueller A, Foerster G, Finkensieper M, Lang-Roth R, Sittel C, Storck C, Grosheva M, Kotby MN, Klingner CM, Guntinas- Lichius O. „Laryngeal electromyography: European Society of Laryngology proposed guidelines”, European Otolarynghology, 2012;269(10):2227–45.
32.
Woźnicka E, Niebudek-Bogusz E, Śliwińska-Kowalska M. Pedagogika efektów głosu w dysfonii porażennej – studium przypadku. Otorynolaryngologia. 2011;10(3):138–145.
33.
Niebudek-Bogusz E, Śliwińska-Kowalska M. Rehabilitacja zawodowych zaburzeń głosu. Instytut Medycyny Pracy im. prof. J. Nofera. 2009; 21–22.
34.
Sielska-Badurek E, Niemczyk K. Postępowanie diagnostyczne w zaburzeniach głosu. Polski przegląd otorynolaryngologiczny. 2015; 12–18.
35.
Głód M. Analiza czynników ryzyka zaburzeń fonacji po operacjach tarczycy. Wroclaw Medical University; 2021.
36.
Kamiya H, Zhang W, Ekberg K, Wahren J, Sima A. C-peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes. 2006;55:3581–3587.
37.
Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019 Jul;29(5):285–295.
38.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343–1421.
39.
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nurs Stand. 2022 Jan 5;37(1):61–66. doi: 10.7748/ns.2021.e11709. Epub 2021 Oct 28. PMID: 34708622.
40.
Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M. Sjögren syndrome. Nat Rev Dis Primers. 2016 Jul 7;2:16047. doi: 10.1038/nrdp.2016.47. PMID: 27383445.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.